Peptides DB
Research-centric peptide and protocol reference hub
Study 27 of 28HMG (Human Menopausal Gonadotropin) literatureResearch in pharmaceutical sciences · Observational · Preclinical2026

<i>Ficus elastica</i> phytochemicals mitigate hyperlipidemia <i>via</i> potential HMG-CoA reductase inhibition, reduced oxidative stress, and tissue preservation.

Ficus elastica phytochemicals showed potential antihyperlipidemic effects in a rat model, but further research is needed to assess their relevance in humans.

Read at Research in pharmaceutical sciencesAdd to compare

Where it sits

this study against the rest of the hmg (human menopausal gonadotropin) corpus
1
Preclinical
21
Observational · this one
0
Open-label
3
Randomised
3
Reviews

Summary and findings

This study investigated the antihyperlipidemic and antioxidant properties of Ficus elastica phytochemicals in rats fed a high-fat diet. Subfraction 4 demonstrated HMG-CoA reductase inhibitory activity and improved lipid parameters compared to simvastatin. The study also reported a reduction in serum malondialdehyde and histological preservation of aortic endothelial integrity.

How much of this paper we could read: full text read (0.70). We had a clear abstract, so the summary below closely tracks the paper. What this means →
Not reported in abstract.Preclinical2026

Abstract

The authors’ words, as Research in pharmaceutical sciences supplied them

<h4>Background and purpose</h4>Hyperlipidemia remains a major cardiovascular risk factor requiring novel therapeutic strategies beyond conventional statin therapy. This study investigated the antihyperlipidemic and antioxidant properties of <i>Ficus elastica</i> Roxb. ex Hornem. (Moraceae) phytochemicals through integrated <i>in vitro, in vivo</i>, and <i>in silico</i> approaches.<h4>Experimental approach</h4>Eight chromatographic subfractions were screened for 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitory activity. Lipid profile, lipid peroxidation, and histopathology were evaluated in rats fed a high-fat diet to induce hyperlipidemia. Chemical composition was characterized using liquid chromatography high-resolution mass spectrometry (LC-HRMS) and subsequently investigated through molecular docking simulations.<h4>Findings/results</h4>Subfraction 4 demonstrated the strongest HMG-CoA reductase inhibitory activity. <i>In vivo</i> evaluation in high-fat diet-induced hyperlipidemic rats revealed dose-dependent improvements in all lipid parameters, with effects statistically comparable to simvastatin. Subfraction 4 additionally reduced serum malondialdehyde to levels statistically indistinguishable from normal controls, indicating restoration of oxidative homeostasis. Histological preservation of aortic endothelial integrity and elastic fiber organization was associated with reduced intima-media thickness, suggesting attenuation of early atherosclerotic changes. LC-HRMS analysis tentatively identified four major constituents, including phlorin, clausarinol, ginsenoyne C, and piptolinic acid A. Molecular docking analysis suggested that clausarinol and ginsenoyne C exhibited comparatively higher predicted binding affinity than simvastatin toward PCSK9 and PPAR-α, respectively.<h4>Conclusion and implications</h4>These findings support the potential of <i>F. elastica</i> phytochemicals as candidates for hyperlipidemia management.

Background

Hyperlipidemia is a significant cardiovascular risk factor, necessitating new therapeutic strategies beyond conventional statin therapy. Previous studies have indicated that phytochemicals may possess antihyperlipidemic and antioxidant properties. This study aims to explore the effects of Ficus elastica phytochemicals on lipid profiles and oxidative stress in a high-fat diet-induced hyperlipidemia model in rats.

Methods

The study utilized both in vitro and in vivo approaches, screening eight chromatographic subfractions for HMG-CoA reductase inhibitory activity. Rats were fed a high-fat diet to induce hyperlipidemia, and lipid profiles, lipid peroxidation, and histopathology were evaluated. The chemical composition was characterized using liquid chromatography high-resolution mass spectrometry (LC-HRMS).

Results

Subfraction 4 exhibited the strongest HMG-CoA reductase inhibitory activity. In vivo results demonstrated dose-dependent improvements in lipid parameters, with effects statistically comparable to simvastatin. Additionally, subfraction 4 reduced serum malondialdehyde to levels statistically indistinguishable from normal controls, indicating a restoration of oxidative homeostasis.

Interpretation

The findings suggest that Ficus elastica phytochemicals may have potential as antihyperlipidemic agents, comparable to known treatments like simvastatin. However, the clinical significance of these results remains uncertain, particularly given the study's rodent model and the need for further research in human populations. The small sample size and potential confounding factors limit the conclusions that can be drawn.

Key findings

  • Subfraction 4 demonstrated the strongest HMG-CoA reductase inhibitory activity.
  • In vivo evaluation revealed dose-dependent improvements in all lipid parameters, with effects statistically comparable to simvastatin.
  • Subfraction 4 reduced serum malondialdehyde to levels statistically indistinguishable from normal controls.
  • Histological preservation of aortic endothelial integrity and elastic fiber organization was associated with reduced intima-media thickness.

Limitations

  • Rodent model may not fully translate to human outcomes.
  • Small sample size in the study.
  • Short duration of the study may not capture long-term effects.
  • Not all relevant clinical endpoints were evaluated.

Elsewhere in the HMG (Human Menopausal Gonadotropin) corpus

BFollitropin delta versus human menopausal gonadotropin in progestin protocol cycles: a retrospective cohort study using inverse probability of treatment weighting.European journal of obstetrics, gynecology, and reproductive biology · 2026 · n=716 · FD yielded more retrieved oocytes than hMG (adjusted mean difference 2.11; 95% CI 0.57-3.65)HumanCsox17 Mutagenesis Reveals Compounding Effects ofMaternal and Zygotic Contribution on Microglia Abundance.Glia · 2026 · Not reported in abstract.AnimalBReal-world utilization of gonadotropins and the associated cumulative live birth rates in the United States: a retrospective claims database analysis.Journal of medical economics · 2026 · n=14174 · Adjusted odds of live birth were 1.31 (95% CI: 1.20-1.45) for mixed protocol compared to follitropin alfa.reviewCMetabolomics-based screening identifies Aspergillus strains that accumulate bioactive leucine catabolites and fatty acid ethyl esters in koji mold-ripened cheese.Food research international (Ottawa, Ont.) · 2026 · R > 0.975 correlation between production quantity of HMB, HMG, α-ketoisocaproic acid, and isovaleric acid with initial concentration of l-leucine.In vitroBIs there a difference in ovarian hyperstimulation syndrome rates in freeze-all treatment cycles in high-risk patients treated with different GnRH agonist triggers?Human fertility (Cambridge, England) · 2026 · n=333 · 12-fold increased risk of severe OHSS with Triptorelin-MR compared to other preparations.HumanCA gut microbial odd-chain fatty acid alleviates atherosclerosis in mice.Nature · 2026Animal